Simplify Logo

Full-Time

Scientist – Viral Vaccines

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Mid, Senior

Cambridge, MA, USA

Category
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD. in molecular virology, cell biology, biochemistry, or a related field
  • Experience with vaccine design using reverse vaccinology or computational protein engineering
  • Deep understanding of the structure, function and characterization of SARS-CoV-2 spike, influenza hemagglutinin or other viral entry glycoproteins
  • Previous work with biological sequence or protein structure datasets
  • Understanding of viral phylodynamics and experience with viral pseudotyping
  • Experience with mammalian cell culture and flow cytometry
  • Familiarity with NGS methods and their implementation
Responsibilities
  • Work closely with other molecular biology, immunology and computational scientists within and beyond Apriori Bio, to support the design and deployment of innovative, proprietary assays
  • Perform and oversee critical data-generating experiments
  • Help build the infrastructure of laboratory protocols, tools, and systems to enable focused and rapid discovery and early vaccine pipeline development
  • Apply rigorous methods to interpret emerging data in the context of key scientific questions
  • Build insights and perspectives to help inform Apriori Bio’s scientific, technological, and commercial strategies
  • Identify relevant external findings, tools, and datasets, and build on these as necessary to support company objectives
  • Communicate insights and conclusions to the scientific team and executive management

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.

Help us improve and share your feedback! Did you find this helpful?